Market News & Trends
West’s SmartDose(®) Drug Delivery Technology Platform Selected by Amgen for Pushtronex™ System
On-body Infusor with Prefilled Cartridge to Deliver Monthly Single Dose of Repatha® (evolocumab) West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in…
Ligand Receives $4 Million From Expansion of Two OmniAb License Agreements
Ligand Pharmaceuticals Incorporated recently announced that two recent events relating to its OmniAb platform generated $4 million in combined payments due to Ligand. One event…
Cytokinetics Announces Start of Phase II Clinical Trial
Cytokinetics, Inc. recently announced the start of a randomized, double-blind, placebo-controlled, two-period crossover clinical trial designed to assess the effect of CK-2127107 (CK-107) on physical…
GeoVax Labs Announces Filing of IND Application for HIV Human Clinical Trial
GeoVax Labs, Inc. recently announced the filing of an Investigational New Drug (IND) application with the US FDA for the conduct of the next human…
CordenPharma Enters Oligonucleotide API Manufacturing Market to Further Strengthen CDMO Offering
CordenPharma recently announced its expansion into the oligonucleotide Active Pharmaceutical Ingredient (API) development and manufacturing market. Dr. Christian Ewers, Vice President Operations, CordenPharma, indicated the…
LEO Pharma Enters Biologics Through Strategic Partnership With AstraZeneca
LEO Pharma recently announced it is a significant step closer to realizing its vision of becoming the preferred dermatology care partner following a strategic partnership…
Catalent to Commercially Supply Palatin Technologies’ New Bremelanotide FSD Product in Pen Injectors
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it…
Major Players in Type 2 Diabetes Shifting Focus to Pricing to Maintain Market Share
The highly mature type 2 diabetes (T2D) market, which is forecast to be valued at $58.7 billion by 2025, will see pharmaceutical companies prioritizing competitive…
Catalent to Commercially Supply Palatin Technologies’ New Bremelanotide FSD Product in Pen Injectors
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it…
Major Players in Type 2 Diabetes Shifting Focus to Pricing to Maintain Market Share
The highly mature type 2 diabetes (T2D) market, which is forecast to be valued at $58.7 billion by 2025, will see pharmaceutical companies prioritizing competitive…
MilliporeSigma to Develop Next-Generation Purification Processes
MilliporeSigma has entered a research agreement with the International Vaccine Institute (IVI) of Seoul, South Korea to help develop more robust, scalable vaccine manufacturing processes.…
Kitov's Lead Drug Achieves Manufacturing Milestone Ahead of Planned NDA Filing With US FDA
Kitov Pharmaceuticals, an innovative biopharmaceutical company focused on late-stage drug development, recently announced that Dexcel Pharma, Kitov's manufacturing partner, has successfully completed an initial stability…
Evonik Acquires Transferra Nanosciences Inc.
Evonik and Transferra Nanosciences, Inc., formerly known as Northern Lipids Inc., recently announced they have signed an asset purchase agreement on June 21, 2016, to…
CordenPharma Caponago Announces Successful Approval of New Sterile Injectable Facility
CordenPharma recently announced the completion and approval of its aseptic filling line in CordenPharma Caponago (IT) by the Italian AIFA for clinical and commercial supply.…
Bio-Path Holdings Announces Collaboration With Thomas Jefferson University
Bio-Path Holdings, Inc. recently announced it has entered into a sponsored research agreement with Thomas Jefferson University to investigate DNAbilize antisense DNA technology for the…
XBiotech Signs Exclusive Licensing Agreement With Megapharm
XBiotech Inc., developer of next-generation True Human antibody therapies, recently announced that it has entered into an exclusive licensing agreement with Megapharm Ltd., to commercialize…
Pluristem Reports Data Showing PLX-PAD Cells Effective in Treating Duchenne Muscular Dystrophy
Pluristem Therapeutics Inc. recently reported positive data from preclinical studies of its PLX-PAD cells in the treatment of Duchenne muscular dystrophy. The studies were conducted…
ERT Develops Industry’s First Integration of Continuous Glucose Monitoring Data & eCOA
ERT, a leading provider of high-quality patient data collection solutions for use in clinical drug development, recently announced a data license agreement with Dexcom to…
Cobra Biologics & Alligator Bioscience Extend Drug Development Partnership
Cobra Biologics has recently been contracted to develop a second cell line for Alligator Bioscience AB. Alligator has requested further support from the team at…
Caladrius Subsidiary, PCT, to Manufacture Phase III Cell Therapy Product for Kiadis Pharma
Caladrius Biosciences, Inc. recently announced that PCT has expanded its relationship with Kiadis Pharma by entering into an agreement for the manufacturing of cell therapy…
